XML 103 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Stockholders' Equity (Deficiency) - USD ($)
$ in Thousands
Total
Ordinary shares
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Price Adjustment Shares [Member]
Public and Private Warrant
Beginning balance (in shares) at Dec. 31, 2021   187,680,294            
Beginning balance at Dec. 31, 2021 $ (73,347) $ 0 $ (153,072) $ (85) $ 1,372 $ 78,438    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) 120,805         120,805    
Other comprehensive income (loss) (1,041)       (1,041)      
APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition     13,708          
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 13,708              
Exercise of share option, vested RSUs and ESPP (in shares)   5,333,361            
Stock Issued During Period, Value, Stock Options Exercised     13,735          
Stock Issued During Period, Value, Employee Stock Purchase Plan   $ 0            
RestrictedSponsorShareLiability 0              
Price Adjustment Shares [Member] 0              
Exercise of public warrants (in shares)   500            
Stock Issued During Period, Value, Warrants Exercised   $ 0 5          
Ending balance (in shares) at Dec. 31, 2022   193,014,155            
Ending balance at Dec. 31, 2022 73,865 $ 0 (125,624) (85) 331 199,243    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) (81,100)         (81,100)    
Other comprehensive income (loss) 719       719      
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 18,998   18,998          
Exercise of share option, vested RSUs and ESPP (in shares)   10,216,773            
Stock Issued During Period, Value, Stock Options Exercised     21,730          
Stock Issued During Period, Value, Employee Stock Purchase Plan   $ 0            
RestrictedSponsorShareLiability 0              
Price Adjustment Shares [Member] $ 0              
Ending balance (in shares) at Dec. 31, 2023 203,230,928 203,230,928            
Ending balance at Dec. 31, 2023 $ 34,212 $ 0 (84,896) (85) 1,050 118,143    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) (283,007)         (283,007)    
Other comprehensive income (loss) 1,036       1,036      
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition $ 30,575   30,575          
Exercise of share option, vested RSUs and ESPP (in shares) 5,962,264 9,688,962            
Stock Issued During Period, Value, Stock Options Exercised $ 20,479   20,479          
Stock Issued During Period, Value, Employee Stock Purchase Plan   $ 0            
RestrictedSponsorShareLiability 113,136   113,136          
Price Adjustment Shares [Member] 254,766   254,766          
Publicand PrivateWarrants $ 164,823   164,823          
Conversion of preferred shares (in shares)             11,495,722 10,109,085
Ending balance (in shares) at Dec. 31, 2024 234,524,697              
Ending balance at Dec. 31, 2024 $ 336,020 $ 0 $ 498,883 $ (85) $ 2,086 $ (164,864)